• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPharmacyte Biotech
    Picture of Pharmacyte Biotech logo

    PMCB — Pharmacyte Biotech News Story

    $0.360.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $3.81m
    • Enterprise Value
      -$26.70m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PMCB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PMCB Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM

    Picture of Pharmacyte Biotech logoPharmacyte Biotech
    18/08/2021 14:57
    NASDAQ TRADE HALT  PMCB.O  VOLATILITY TRADING PAUSE AT 09:57 AM
    

    Recent news on Pharmacyte Biotech

    See all news
    • Brief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million

      02/09/2025 17:44
    • Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

      21/05/2024 14:26
    • Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys

      15/11/2023 15:02
    • Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech

      15/11/2023 12:34
    • Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer

      15/06/2023 14:50

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.